Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    23683600 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Denosumab, Teriparatide or Both for the Treatment of Postmenopausal Osteoporosis
Condition: Osteoporosis
Interventions: Drug: denosumab;   Drug: teriparatide

Indicates status has not been verified in more than two years